Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sooraj Achar

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Annual Review of Biophysics|February 5, 2026
Learning the Principles of T Cell Antigen DiscernmentFrançois X P Bourassa, Sooraj Achar, Grégoire Altan-Bonnet, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
The 1000<sup>+</sup> mouse project: large-scale spatiotemporal parametrization and modeling of preclinical cancer immunotherapiesAdam L Kenet, Sooraj Achar, Alka Dwivedi, et al.
Elife|March 24, 2026
The 1000<sup>+</sup> mouse project for large-scale spatiotemporal parametrization and modeling of preclinical cancer immunotherapiesAdam L Kenet, Sooraj Achar, Alka Dwivedi, et al.
Nature Chemical Biology|August 14, 2019
A PCBP1-BolA2 chaperone complex delivers iron for cytosolic [2Fe-2S] cluster assemblySarju J Patel, Avery G Frey, Daniel J Palenchar, et al.
Nature Communications|April 27, 2022
T cell receptor and IL-2 signaling strength control memory CD8<sup>+</sup> T cell functional fitness via chromatin remodelingShu Shien Chin, Erik Guillen, Laurent Chorro, et al.
Nature Immunology|December 6, 2023
Publisher Correction: CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptidesGuillaume Gaud, Sooraj Achar, François X P Bourassa, et al.
Nature Immunology|November 9, 2023
CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptidesGuillaume Gaud, Sooraj Achar, François X P Bourassa, et al.
Molecular Therapy. Methods & Clinical Development|February 1, 2024
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell outputHannah W Song, Mehdi Benzaoui, Alka Dwivedi, et al.
Cell|April 12, 2025
Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificityTaisuke Kondo, François X P Bourassa, Sooraj Achar, et al.
Cytotherapy|November 5, 2025
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategiesAlexandra Dreyzin, Anne Marijn Kramer, Bonnie Yates, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Annual Review of Biophysics|February 5, 2026
Learning the Principles of T Cell Antigen DiscernmentFrançois X P Bourassa, Sooraj Achar, Grégoire Altan-Bonnet, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
The 1000<sup>+</sup> mouse project: large-scale spatiotemporal parametrization and modeling of preclinical cancer immunotherapiesAdam L Kenet, Sooraj Achar, Alka Dwivedi, et al.
Elife|March 24, 2026
The 1000<sup>+</sup> mouse project for large-scale spatiotemporal parametrization and modeling of preclinical cancer immunotherapiesAdam L Kenet, Sooraj Achar, Alka Dwivedi, et al.
Nature Chemical Biology|August 14, 2019
A PCBP1-BolA2 chaperone complex delivers iron for cytosolic [2Fe-2S] cluster assemblySarju J Patel, Avery G Frey, Daniel J Palenchar, et al.
Nature Communications|April 27, 2022
T cell receptor and IL-2 signaling strength control memory CD8<sup>+</sup> T cell functional fitness via chromatin remodelingShu Shien Chin, Erik Guillen, Laurent Chorro, et al.
Nature Immunology|December 6, 2023
Publisher Correction: CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptidesGuillaume Gaud, Sooraj Achar, François X P Bourassa, et al.
Nature Immunology|November 9, 2023
CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptidesGuillaume Gaud, Sooraj Achar, François X P Bourassa, et al.
Molecular Therapy. Methods & Clinical Development|February 1, 2024
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell outputHannah W Song, Mehdi Benzaoui, Alka Dwivedi, et al.
Cell|April 12, 2025
Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificityTaisuke Kondo, François X P Bourassa, Sooraj Achar, et al.
Cytotherapy|November 5, 2025
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategiesAlexandra Dreyzin, Anne Marijn Kramer, Bonnie Yates, et al.
Pageof 2